Decision follows underwhelming Phase II results from GALAXIES Lung-201 and H&N-202 trials, prompting iTeos and GSK to end ...

Ampaire Inc., a leader in hybrid electric aircraft technology, announced today that the Federal Aviation Administration (FAA) ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Denmark, oncology-based Pharmacosmos today announced that it has assumed the worldwide rights, excluding select Asia-Pacific ...

Based on the FS’s updated graphite reserve estimate, the Mine’s life for the purposes of the FS would be 20 years. The FS ...

Emactuzumab, a humanized immunoglobulin G1 monoclonal antibody, targets the CSF-1 receptor and inhibits macrophages in tumor tissue.

Each year, the United States Hockey League holds a draft in two phases. Phase I involves ‘futures’ players who are typically ...

DelveInsight’s Renal Cell Carcinoma Pipeline report depicts a robust space with 30+ active players working to develop 30+ ...

The International Thermonuclear Experimental Reactor (ITER) has reached a major milestone in the pursuit of clean energy. The ...

MS/MS method for detecting eight persistent, mobile, and toxic substances in escarole, tomatoes, and tomato leaves irrigated ...

Net Income/Loss: Net loss was $34.6 million, or net loss of $0.80 per basic and diluted share for the quarter ended March 31, 2025, as compared to a net loss of $38.2 million, or a net loss of $1.07 ...

Arsenal beat reigning champions Real Madrid 5-1 on aggregate in the quarter-finals and will now face French side PSG, who they beat 2-0 in the league phase in October. The Gunners, who have never ...